Abbott investing in Clonmel facility for the research and development of new heart stents

Tipperary facility has developed a new family of stents to treat cardiovascular 

Abbott's vascular R&D facility in Clonmel. Picture: Denis Minihane.

Healthcare multinational Abbott is to invest €37.8m at its heart stent manufacturing facility in Clonmel.

Both the research and development of the new 'Xience' family of devices along with the manufacturing will take place at the Tipperary facility.